Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-10

Clinical Trial Update: Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion of a placebo-controlled Phase 2/3 trial evaluating the efficacy and safety of vardenafil for erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vardenafil (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 2, Phase 3 | Status: COMPLETED